![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Seroprevalence of SARS-CoV-2 in Niger State: A Pilot Cross Sectional Study
Hussaini Majiya, Mohammed Aliyu‐Paiko, Tochukwu Vincent Balogu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 48
Hussaini Majiya, Mohammed Aliyu‐Paiko, Tochukwu Vincent Balogu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 237
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 237
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
Lloyd Mulenga, Jonas Z. Hines, Sombo Fwoloshi, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 6, pp. e773-e781
Open Access | Times Cited: 140
Lloyd Mulenga, Jonas Z. Hines, Sombo Fwoloshi, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 6, pp. e773-e781
Open Access | Times Cited: 140
Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes among Adults to Receive COVID-19 Vaccines in Ghana
Theophilus Acheampong, Eli A. Akorsikumah, John Osae-Kwapong, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 814-814
Open Access | Times Cited: 122
Theophilus Acheampong, Eli A. Akorsikumah, John Osae-Kwapong, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 814-814
Open Access | Times Cited: 122
Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa
Benjamin L. Rice, Akshaya V. Annapragada, Rachel E. Baker, et al.
Nature Medicine (2021) Vol. 27, Iss. 3, pp. 447-453
Open Access | Times Cited: 100
Benjamin L. Rice, Akshaya V. Annapragada, Rachel E. Baker, et al.
Nature Medicine (2021) Vol. 27, Iss. 3, pp. 447-453
Open Access | Times Cited: 100
Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa
Jane Shaw, Maynard Meiring, Tracy Cummins, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0247852-e0247852
Open Access | Times Cited: 55
Jane Shaw, Maynard Meiring, Tracy Cummins, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0247852-e0247852
Open Access | Times Cited: 55
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
Kene David Nwosu, Joseph Fokam, Franck Wanda, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Kene David Nwosu, Joseph Fokam, Franck Wanda, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020
Anup Malani, Daksha Shah, Gagandeep Kang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 39
Anup Malani, Daksha Shah, Gagandeep Kang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 39
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 35
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 35
Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe
Arun Fryatt, Victoria Simms, Tsitsi Bandason, et al.
EClinicalMedicine (2021) Vol. 41, pp. 101172-101172
Open Access | Times Cited: 30
Arun Fryatt, Victoria Simms, Tsitsi Bandason, et al.
EClinicalMedicine (2021) Vol. 41, pp. 101172-101172
Open Access | Times Cited: 30
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
Kirsten E. Wiens, Pinyi Nyimol Mawien, John Rumunu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 29
Kirsten E. Wiens, Pinyi Nyimol Mawien, John Rumunu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 29
Revealing the extent of the COVID-19 pandemic in Kenya based on serological and PCR-test data
John Ojal, Samuel P. C. Brand, Vincent Were, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 27
John Ojal, Samuel P. C. Brand, Vincent Were, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 27
High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses
Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, et al.
Journal of Clinical Virology Plus (2023) Vol. 3, Iss. 3, pp. 100156-100156
Open Access | Times Cited: 9
Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, et al.
Journal of Clinical Virology Plus (2023) Vol. 3, Iss. 3, pp. 100156-100156
Open Access | Times Cited: 9
SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria
Olatunji Matthew Kolawole, Oyewale Tomori, D. E. Agbonlahor, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236053-e2236053
Open Access | Times Cited: 13
Olatunji Matthew Kolawole, Oyewale Tomori, D. E. Agbonlahor, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236053-e2236053
Open Access | Times Cited: 13
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
John Ojal, Samuel P. C. Brand, Vincent Were, et al.
Wellcome Open Research (2021) Vol. 6, pp. 127-127
Open Access | Times Cited: 19
John Ojal, Samuel P. C. Brand, Vincent Were, et al.
Wellcome Open Research (2021) Vol. 6, pp. 127-127
Open Access | Times Cited: 19
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study
Issaka Sagara, John Woodford, Mamady Kone, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Issaka Sagara, John Woodford, Mamady Kone, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020
Enyew Birru Tadesse, Abduilhafiz A. Endris, Henok Solomon, et al.
International Journal of Infectious Diseases (2021) Vol. 111, pp. 179-185
Open Access | Times Cited: 15
Enyew Birru Tadesse, Abduilhafiz A. Endris, Henok Solomon, et al.
International Journal of Infectious Diseases (2021) Vol. 111, pp. 179-185
Open Access | Times Cited: 15
Population-based prevalence surveys during the COVID-19 pandemic: a systematic review
Vinícius Bonetti Franceschi, Andressa Schneiders Santos, Andressa Barreto Glaeser, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 13
Vinícius Bonetti Franceschi, Andressa Schneiders Santos, Andressa Barreto Glaeser, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 13
High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey
Helmut Nyawale, Nyambura Moremi, Mohamed Mohamed, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 18, pp. 11664-11664
Open Access | Times Cited: 8
Helmut Nyawale, Nyambura Moremi, Mohamed Mohamed, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 18, pp. 11664-11664
Open Access | Times Cited: 8
SARS-CoV-2 infection in Ivory Coast: a serosurveillance survey among gold mine workers
Jean Marie Milleliri, Daouda Coulibaly, Blaise Nyobe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 9
Jean Marie Milleliri, Daouda Coulibaly, Blaise Nyobe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 9
Estimating the Percentage of a Population Infected with SARS-CoV-2 Using the Number of Reported Deaths: A Policy Planning Tool
Daniel R. Feikin, Marc‐Alain Widdowson, Kim Mulholland
Pathogens (2020) Vol. 9, Iss. 10, pp. 838-838
Open Access | Times Cited: 9
Daniel R. Feikin, Marc‐Alain Widdowson, Kim Mulholland
Pathogens (2020) Vol. 9, Iss. 10, pp. 838-838
Open Access | Times Cited: 9
Evaluating alternative hypotheses to explain the downward trend in the indices of the COVID-19 pandemic death rate
Sonali Shinde, Pratima Ranade, Milind Watve
PeerJ (2021) Vol. 9, pp. e11150-e11150
Open Access | Times Cited: 8
Sonali Shinde, Pratima Ranade, Milind Watve
PeerJ (2021) Vol. 9, pp. e11150-e11150
Open Access | Times Cited: 8
Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data
Harlan Campbell, Paul Gustafson
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Harlan Campbell, Paul Gustafson
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Regional comparisons of COVID reporting rates, burden, and mortality age-structure using auxiliary data sources
Mollie M. Van Gordon, Lawrence Mwananyanda, Christopher Gill, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Mollie M. Van Gordon, Lawrence Mwananyanda, Christopher Gill, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Seroprevalence of SARS-CoV-2 IgG among healthcare workers in Lagos, Nigeria
Fehintola Ige, Gregory Aigbe Ohihoin, Kazeem Adewale Osuolale, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292440-e0292440
Open Access | Times Cited: 2
Fehintola Ige, Gregory Aigbe Ohihoin, Kazeem Adewale Osuolale, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292440-e0292440
Open Access | Times Cited: 2
Seropositivity of SARS-CoV-2 IgG Antibody among People in Dhaka City during the Prevaccination Period
Zabed Bin Ahmed, Mamudul Hasan Razu, Fatema Akter, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 4
Zabed Bin Ahmed, Mamudul Hasan Razu, Fatema Akter, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 4